secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001185185-22-001432
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC posts updated life sciences presentation on website; no financial or clinical updates
--------------------------------------------------------------------------------

- Presentation covers low-dose THC drug formulation and disease treatment initiatives.
- Also highlights cannabinoid consumer product lines including Holief and Sunday Seltzer.
- No new clinical trial results, partnerships, or revenue guidance disclosed.
- Presentation available at igcpharma.com and filed as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522001432/0001185185-22-001432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522001432/indiaglob20221219_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-22-001432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer